IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,595 | +96.5% | 9,419 | -2.9% | 0.00% | +100.0% |
| Q2 2023 | $184,009 | +100.4% | 9,700 | +63.9% | 0.00% | – |
| Q1 2023 | $91,819 | -29.1% | 5,920 | -18.8% | 0.00% | -100.0% |
| Q4 2022 | $129,433 | +187.6% | 7,292 | -9.7% | 0.00% | – |
| Q3 2022 | $45,000 | +45.2% | 8,076 | 0.0% | 0.00% | – |
| Q2 2022 | $31,000 | -29.5% | 8,076 | 0.0% | 0.00% | – |
| Q1 2022 | $44,000 | -8.3% | 8,076 | +43.4% | 0.00% | – |
| Q4 2021 | $48,000 | -4.0% | 5,631 | -2.1% | 0.00% | – |
| Q3 2021 | $50,000 | -18.0% | 5,751 | -0.1% | 0.00% | – |
| Q2 2021 | $61,000 | -33.7% | 5,757 | +0.9% | 0.00% | -100.0% |
| Q1 2021 | $92,000 | -55.6% | 5,705 | +27.2% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | +65.6% | 4,484 | +26.1% | 0.00% | 0.0% |
| Q3 2020 | $125,000 | – | 3,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |